Rabbit Recombinant Monoclonal TCF-4 antibody. Carrier free. Suitable for ChIP, IHC-P, WB, Flow Cyt (Intra) and reacts with Human, Mouse samples. Cited in 1 publication.
IgG
Rabbit
pH: 7.2 - 7.4
Constituents: PBS
Liquid
Monoclonal
ChIP | IHC-P | WB | Flow Cyt (Intra) | |
---|---|---|---|---|
Human | Tested | Tested | Tested | Tested |
Mouse | Not recommended | Not recommended | Tested | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes Fixative: 4% Formalin |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info - | Notes Fixative: 4% Formalin |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info - | Notes - |
Select an associated product type
Transcription factor that binds to the immunoglobulin enhancer Mu-E5/KE5-motif. Involved in the initiation of neuronal differentiation. Activates transcription by binding to the E box (5'-CANNTG-3'). Binds to the E-box present in the somatostatin receptor 2 initiator element (SSTR2-INR) to activate transcription (By similarity). Preferentially binds to either 5'-ACANNTGT-3' or 5'-CCANNTGG-3'.
BHLHB19, ITF2, SEF2, TCF4, Transcription factor 4, TCF-4, Class B basic helix-loop-helix protein 19, Immunoglobulin transcription factor 2, SL3-3 enhancer factor 2, bHLHb19, ITF-2, SEF-2
Rabbit Recombinant Monoclonal TCF-4 antibody. Carrier free. Suitable for ChIP, IHC-P, WB, Flow Cyt (Intra) and reacts with Human, Mouse samples. Cited in 1 publication.
IgG
Rabbit
pH: 7.2 - 7.4
Constituents: PBS
Liquid
Monoclonal
Yes
NCI-R159-6
Affinity purification Protein A
Mouse specificity in WB only.Weak human specificity in IHC.
Blue Ice
+4°C
+4°C
Do Not Freeze
ab223073 is the carrier-free version of Anti-TCF-4 antibody [NCI-R159-6] ab217668.
For detailed protocol using this antibody for IHC, ChIP, and Flow Cyt, please refer to the following paper: Ceribelli et al. A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm, PMID: 27846392
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
This supplementary information is collated from multiple sources and compiled automatically.
The transcription factor 4 (TCF-4) also known as TCF7L2 is an important regulator of transcriptional activity. This protein weighs approximately 68 kDa and is widely expressed in multiple tissues including the pancreas intestine and brain. Through its function as a transcription factor TCF-4 binds to specific DNA sequences influencing the expression of target genes. The regulation it provides is essential for various biological processes especially during developmental stages.
TCF-4 plays an important role in Wnt signaling a pathway critical for cell growth and differentiation. It partners with β-catenin to form a functional complex enabling it to activate gene expression. This interaction influences cellular processes such as cell cycle regulation fate determination and maintenance of stem cell populations. As such TCF-4 serves an important role in regulating a balance between proliferation and differentiation in developing tissues.
TCF-4 is an important component within the canonical Wnt/β-catenin signaling pathway. This pathway is pivotal in embryogenesis and is also involved in the control of cell communication processes. TCF-4 interacts with other pathway members such as the APC protein which are essential for stabilizing β-catenin enabling successful transcriptional regulation. Its activity connects it chemically to the TCF/LEF family of proteins which all participate actively in gene transcription related to Wnt signaling.
TCF-4 has been implicated in type 2 diabetes and certain forms of cancer. Research shows that mutations in the TCF7L2 gene alter its function leading to increased susceptibility to type 2 diabetes emphasizing its role in glucose metabolism. Moreover dysregulation of the Wnt signaling pathway in which TCF-4 is an actor has been associated with cancer pathogenesis including colorectal cancer. TCF-4 connects closely with β-catenin and APC in these conditions highlighting its involvement in tumorigenic processes when its regulation fails.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Immunohistochemical analysis of 4% Formalin fixed Blastic plasmacytoid dendritic cell neoplasm (BPDCN) cell pellets after selection and induction of shRNA expression for 1 day, labeling TCF-4 with Anti-TCF-4 antibody [NCI-R159-6] ab217668 at 1/100 dilution. Universal DAB Detection Kit was used for detection of IHC staining on an automated system.
The data was provided by our collaborator Dr. Louis M. Staudt, and published in Cancer Cell 30, 764-778, 2016 (PMID: 27846392). Several TCF-4 shRNAs were used. This IHC image shows data for shRNA TCF-4 #2.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-TCF-4 antibody [NCI-R159-6] ab217668).
Immunohistochemical analysis of 4% Formalin fixed human tonsil labeling TCF-4 with Anti-TCF-4 antibody [NCI-R159-6] ab217668 at 1/100 dilution. Universal DAB Detection Kit was used for detection of IHC staining on an automated system.
pDCs: plasmacytoid dendritic cells.
GC: Germinal Center.
The data was provided by our collaborator Dr. Louis M. Staudt, and published in Cancer Cell 30, 764-778, 2016 (PMID: 27846392).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-TCF-4 antibody [NCI-R159-6] ab217668).
Cal-1 cells (Human plasmacytoid dendritic cell line) were cross-linked with 1% formaldehyde for 5 min at RT. Cross-linked cells were first washed with ice-cold PBS and then resuspended in ice-cold RIPA buffer (10mM Tris-HCl pH8, 140 mM NaCl, 1mM EDTA pH 8, 0.5 mM EGTA, 1% Triton X-100, 0.1% SDS and 0.1% Sodium Deoxycholate) to a final concentration of 5x106 cells/ml. DNA was sheared with a Misonix XL sonicator, by performing 12 x 45'' sonication cycles at power setting of 5. For each ChIP reaction, 2x107 chromatin cell equivalents were incubated overnight with10 μg of Anti-TCF-4 antibody [NCI-R159-6] ab217668. The following day, chromatin/antibody complexes were incubated with 50 μl of Protein G/Protein A magnetic beads mix (G to A ratio 3:1) for 4 h at 4°C. Normal rabbit IgG was added to the beads as control.
The TCF-4 locus ChIP-seq tracks for BRD4 (blue), RNA Pol2 (red), and TCF-4 (green) are shown for Cal-1 cells. This data was kindly provided by our collaborator Dr. Louis M. Staudt, and has been published (PMID: 27846392).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-TCF-4 antibody [NCI-R159-6] ab217668).
Intracellular flow cytometric analysis of 1% paraformaldehyde-fixed, ice-cold methanol permeabilized Cal-1 cells (Human plasmacytoid dendritic cell line) (black - positive control) and Cal-1 cells infected with either Ctrl (left green) or TCF4 (right green) shRNA, labeling TCF4 with Anti-TCF-4 antibody [NCI-R159-6] ab217668 at 1/100 dilution (green and black) compared with a Rabbit IgG control (grey). Goat anti-Rabbit IgG (Alexa Fluor® 647) at 1/500 dilution was used as the secondary antibody.
The data was provided by our collaborator Dr. Louis M. Staudt, and published in Cancer Cell 30, 764-778, 2016 (PMID: 27846392). Several TCF4 shRNAs were used. This FC image shows data for shRNA TCF4
1.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-TCF-4 antibody [NCI-R159-6] ab217668).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-TCF-4 antibody [NCI-R159-6] ab217668).
Blocking/Dilution buffer: 5% NFDM/TBST.
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
All lanes: Western blot - Anti-TCF-4 antibody [NCI-R159-6] (Anti-TCF-4 antibody [NCI-R159-6] ab217668) at 1/1000 dilution
Lane 1: Daudi (human Burkitt's lymphoma lymphoblast) cytoplasmic fraction at 20 µg
Lane 2: Daudi nuclear fraction at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Developed using the ECL technique.
Predicted band size: 71 kDa
Observed band size: 58 kDa, 79 kDa
Exposure time: 3min
Blocking/Dilution buffer: 5% NFDM/TBST.
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-TCF-4 antibody [NCI-R159-6] ab217668).
Blocking/Dilution buffer: 5% NFDM/TBST.
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
All lanes: Western blot - Anti-TCF-4 antibody [NCI-R159-6] (Anti-TCF-4 antibody [NCI-R159-6] ab217668) at 1/1000 dilution
Lane 1: U-87 MG (human glioblastoma-astrocytoma epithelial cell), whole cell lysate at 20 µg
Lane 2: Neuro-2a (mouse neuroblastoma neuroblast), whole cell lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Developed using the ECL technique.
Predicted band size: 71 kDa
Observed band size: 58 kDa, 79 kDa
Exposure time: 3min
Blocking/Dilution buffer: 5% NFDM/TBST.
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
This data was developed using Anti-TCF-4 antibody [NCI-R159-6] ab217668, the same antibody clone in a different buffer formulation.
Flow cytometry overlay histogram showing SH-SY5Y cells stained with Anti-TCF-4 antibody [NCI-R159-6] ab217668 (red line). The cells were fixed with 4% formaldehyde (10 min) and then permeabilised with 0.1% PBS-Triton X-100 for 15 min. The cells were incubated in nan followed by the antibody (Anti-TCF-4 antibody [NCI-R159-6] ab217668) (1x 106in 100µl at 0.1µg/ml (1/19400)) for 30min at 22°C.
The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min at 22°C
Isotype control antibody (black line) was Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.
Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.
This antibody gave a positive signal in SH-SY5Y Fixed with 80% methanol (5 min) / permeabilised with 0.1% PBS-Triton X-100 for 15 min under the same conditions.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com